최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Bioorganic chemistry, v.87, 2019년, pp.43 - 55
Ullah, Sultan (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Park, Chaeun (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Ikram, Muhammad (Department of Anatomy, Pusan National University School of Medicine) , Kang, Dongwan (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Lee, Sanggwon (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Yang, Jungho (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Park, Yujin (Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University) , Yoon, Sik (Department of Anatomy, Pusan National University School of Medicine) , Chun, Pusoon (College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University Sou) , Moon, Hyung Ryong
Abstract Abnormal melanogenesis results in excessive production of melanin, leading to pigmentation disorders. As a key and rate-limiting enzyme for melanogenesis, tyrosinase has been considered an important target for developing therapeutic agents of pigment disorders. Despite having an (E)-β...
Photochem. Photobiol. Brenner 84 3 539 2008 10.1111/j.1751-1097.2007.00226.x The protective role of melanin against UV damage in human skin
R. King, J. Nordlund, R. Boissy, V. Hearing, The pigmentary system: physiology and pathophysiology; 1998.
Exp. Opin. Ther. Pat. Ullah 26 3 347 2016 10.1517/13543776.2016.1146253 Tyrosinase inhibitors: a patent review (2011-2015)
Pigm. Cell Res. Kim 19 1 90 2006 10.1111/j.1600-0749.2005.00281.x Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression
Biosci. Biotechnol. Biochem. Sawai-Hatanaka 59 7 1221 1995 10.1271/bbb.59.1221 Cloning, sequencing, and heterologous expression of a gene coding for arthromyces ramosus peroxidase
Pigm. Cell Res. Barral 17 2 111 2004 10.1111/j.1600-0749.2004.00138.x The melanosome as a model to study organelle motility in mammals
J. Am. Acad. Dermatol. Kameyama 34 1 29 1996 10.1016/S0190-9622(96)90830-0 Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo
J. Invest. Dermatol. Penney 82 4 308 1984 10.1111/1523-1747.ep12260588 Depigmenting action of hydroquinone depends on disruption of fundamental cell processes
Cell. Mole. Life Sci. CMLS Kim 62 15 1707 2005 10.1007/s00018-005-5054-y Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future
Int. J. Mol. Sci. Chang 10 6 2440 2009 10.3390/ijms10062440 An updated review of tyrosinase inhibitors
J. Pharm. Pharmacol. Cabanes 46 12 982 1994 10.1111/j.2042-7158.1994.tb03253.x Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase
Biochem. Biophys. Res. Commun. Shin 243 3 801 1998 10.1006/bbrc.1998.8169 Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase
Biorg. Med. Chem. Khatib 13 2 433 2005 10.1016/j.bmc.2004.10.010 Chalcones as potent tyrosinase inhibitors: the importance of a 2, 4-substituted resorcinol moiety
Biosci. Biotechnol. Biochem. Jung 82 5 759 2018 10.1080/09168451.2018.1445518 A novel synthetic compound,(Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-iminothiazolidin-4-one (MHY773) inhibits mushroom tyrosinase
Biorg. Med. Chem. Kim 2018 10.1016/j.bmc.2018.05.047 The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold
Drug Des. Devel. Ther. Do Hyun Kim 11 827 2017 10.2147/DDDT.S131538 Design, synthesis, and antimelanogenic effects of (2-substituted phenyl-1, 3-dithiolan-4-yl) methanol derivatives
Drug Des. Devel. Ther. Yun 9 4259 2015 Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl) acrylonitriles
Phytother. Res.: Int. J. Dev. Pharmacol. Toxicol. Eval. Natural Product Deriv. Parvez 20 11 921 2006 10.1002/ptr.1954 Survey and mechanism of skin depigmenting and lightening agents
Biochem. Pharmacol. Curto 57 6 663 1999 10.1016/S0006-2952(98)00340-2 Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors
Int. J. Cosmet. Sci. Hermanns 22 1 67 2000 10.1046/j.1467-2494.2000.00021.x Skin colour assessment in safety testing of cosmetics. An overview
Nature Fuyuno 432 7020 938 2004 10.1038/432938a Spotlight turns on cosmetics for Asian skin
Sci. Rep. Chen 5 7995 2015 10.1038/srep07995 Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling
Mutat. Res./Genetic Toxicol. Environ. Mutagen. Ogiwara 780 111 2015 10.1016/j.mrgentox.2015.01.004 Evaluation of the repeated-dose liver, bone marrow and peripheral blood micronucleus and comet assays using kojic acid
J. Cosmet. Dermatol. Westerhof 4 2 55 2005 10.1111/j.1473-2165.2005.40202.x Hydroquinone and its analogues in dermatology-a potential health risk
J. Pharmacol. Exp. Ther. Maeda 276 2 765 1996 Arbutin: mechanism of its depigmenting action in human melanocyte culture
Chem. Biol. Interact. Gaskell 153 267 2005 10.1016/j.cbi.2005.03.034 Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone
J. Cosmet. Dermatol. Bang 7 3 189 2008 10.1111/j.1473-2165.2008.00387.x Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity
Pharmazeutische Industrie Coiffard 61 6 574 1999 Degradation kinetics of arbutin in solution
Angew. Chem. Int. Ed. Decker 45 28 4546 2006 10.1002/anie.200601255 The first crystal structure of tyrosinase: all questions answered?
Anal. Chem. Burestedt 68 9 1605 1996 10.1021/ac950742o Rate-limiting steps of tyrosinase-modified electrodes for the detection of catechol
Biosci. Biotechnol. Biochem. Chang 69 10 1999 2005 10.1271/bbb.69.1999 Identifying 6, 7, 4′-trihydroxyisoflavone as a potent tyrosinase inhibitor
Biochim. et Biophys. Acta (BBA)-General Sub. Chung 1830 10 4752 2013 10.1016/j.bbagen.2013.06.002 Characterization of a small molecule inhibitor of melanogenesis that inhibits tyrosinase activity and scavenges nitric oxide (NO)
Bioorg. Med. Chem. Lett. Choi 24 5 1344 2014 10.1016/j.bmcl.2014.01.040 MHY884, a newly synthesized tyrosinase inhibitor, suppresses UVB-induced activation of NF-κB signaling pathway through the downregulation of oxidative stress
MedChemComm Kim 5 9 1410 2014 10.1039/C4MD00171K Benzylidene-linked thiohydantoin derivatives as inhibitors of tyrosinase and melanogenesis: importance of the β-phenyl-α, β-unsaturated carbonyl functionality
Arch. Pharm. Res. Kim 36 10 1189 2013 10.1007/s12272-013-0184-5 Anti-melanogenic effect of (Z)-5-(2, 4-dihydroxybenzylidene) thiazolidine-2, 4-dione, a novel tyrosinase inhibitor
Biorg. Med. Chem. Son 23 24 7728 2015 10.1016/j.bmc.2015.11.015 (E)-2-Cyano-3-(substituted phenyl) acrylamide analogs as potent inhibitors of tyrosinase: a linear β-phenyl-α, β-unsaturated carbonyl scaffold
Biorg. Med. Chem. Kubo 8 7 1749 2000 10.1016/S0968-0896(00)00102-4 Flavonols from heterotheca inuloides: tyrosinase inhibitory activity and structural criteria
J. Agric. Food Chem. Iwai 52 15 4893 2004 10.1021/jf040048m In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans
Biol. Pharm. Bull. Kang 38 8 1227 2015 10.1248/bpb.b15-00300 (Z)-2-(Benzo [d] thiazol-2-ylamino)-5-(substituted benzylidene) thiazol-4 (5H)-one derivatives as novel tyrosinase inhibitors
Biochim. et Biophys. Acta (BBA)-General Sub. Chung 1820 7 962 2012 10.1016/j.bbagen.2012.03.018 Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2, 4 dihydroxybenzylidene) pyrrolidine-2, 5-dione (3-DBP)
Biochim. et Biophys. Acta (BBA)-General Sub. Han 1820 4 542 2012 10.1016/j.bbagen.2012.01.001 Characterization of a novel tyrosinase inhibitor,(2RS, 4R)-2-(2, 4-dihydroxyphenyl) thiazolidine-4-carboxylic acid (MHY384)
Tetrahedron Lett. Singh 55 52 7243 2014 10.1016/j.tetlet.2014.11.053 Choline chloride based deep eutectic solvent as an efficient solvent for the benzylation of phenols
Biorg. Med. Chem. Wan 12 13 3521 2004 10.1016/j.bmc.2004.04.033 Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors
J. Med. Chem. Remiszewski 45 4 753 2002 10.1021/jm015568c Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates
Biol. Pharm. Bull. Hyun 31 1 154 2008 10.1248/bpb.31.154 Inhibitory effects of kurarinol, kuraridinol, and trifolirhizin from Sophora flavescens on tyrosinase and melanin synthesis
J. Comput. Chem. Morris 19 14 1639 1998 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
J. Comput. Aided Mol. Des. Moustakas 20 10-11 601 2006 10.1007/s10822-006-9060-4 Development and validation of a modular, extensible docking program: DOCK 5
Biol. Pharm. Bull. Ishiyama 19 11 1518 1996 10.1248/bpb.19.1518 A combined assay of cell vability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet
Biosci. Biotechnol. Biochem. Bae 77 1 65 2013 10.1271/bbb.120547 A novel synthesized tyrosinase inhibitor:(E)-2-((2, 4-dihydroxyphenyl) diazenyl) phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog
Biol. Pharm. Bull. Chen 32 8 1447 2009 10.1248/bpb.32.1447 Melanogenesis inhibition by gallotannins from Chinese galls in B16 mouse melanoma cells
RSC Adv. Matos 5 114 94227 2015 10.1039/C5RA14465E Design and discovery of tyrosinase inhibitors based on a coumarin scaffold
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.